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Background. In folk medicine, common chickweed (Stellaria media) has traditionally been applied for the treatment of hy-
percholesterolemia; however, there is no ﬁrm experimental proof to support the rationale of this practice. /erefore, we aimed to
assess the eﬃcacy and safety of Stellaria media tea in hypercholesterolemic rats. Materials and Methods. Adult male Wistar rats
were divided into 3 groups./e (i) control group received standard laboratory chow, the (ii) hypercholesterolemic group received
cholesterol-enriched diet, and the (iii) chickweed-treated hypercholesterolemic group received cholesterol-enriched diet and
100mg/kg body weight Stellaria media tea lyophilizate for 8 weeks. Blood samples were collected to determine serum lipid proﬁle
as well as liver and kidney function, and echocardiography was performed to assess cardiac morphology and function. Results.
Cholesterol-enriched diet signiﬁcantly increased serum total cholesterol, LDL- and HDL-cholesterol levels, but did not aﬀect
triacylglycerol concentrations. /e addition of chickweed to the diet did not cause any signiﬁcant change in serum lipid proﬁle or
body weight increase. Liver and kidney functions were unaltered and cardiac morphology and function were not changed due to
Stellaria media tea lyophilizate.Conclusion. Although chickweed does not seem to be toxic, our results do not support the rationale
of its use in the treatment of hypercholesterolemia.
1. Introduction
/e wide ecological tolerance and short-term vegetative
reproduction period make chickweed (Stellaria media (L.)
Vill., Caryophyllaceae) a common and widespread species.
In cool, moist, and moderately shaded environment, huge
territories are covered by this plant; thus, its presence in
cultivated ﬁelds is a serious agricultural problem.
Although chickweed has been consumed as salad and has
been applied in folk medicine as tea [1, 2], its safety and
eﬃcacy have not been investigated in clinical trials [3].
Moderate interest has been shown toward this plant from the
middle of the last century. Because of the potential biological
beneﬁts and its application in cosmetics, phytochemical and
pharmacological studies have started to focus on species of
Stellaria genus. /ese studies are based mainly on in vitro or
in vivo animal experiments. According to these studies,
several Stellaria species have noteworthy pharmacological
activities (e.g., antibacterial, anti-inﬂammatory, and anti-
allergic eﬀects) [4].
Nowadays, Stellaria media, mostly consumed as tea, is
gaining popularity as a remedy to lose weight [5] and it is
widely used for its believed beneﬁcial eﬀects on blood lipid
proﬁle [6]. According to a popular Hungarian traditional
healer, the infusion of 2.5 g chickweed two times daily
normalizes increased cholesterol level within some weeks
[7]. Moreover, consumption of chickweed tea for cholesterol
lowering is recommended by several websites dealing with
health and lifestyle issues [8, 9]. Since there is no clinical
evidence supporting this hypothesis and the designs of the
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available animal experiments diﬀer from the human use, the
aim of the present work was the investigation of chickweed
tea on rats to gather additional data on eﬃcacy and safety.
2. Methods and Materials
2.1. Animals. /e experiment conforms to the Guide for the
Care and Use of Laboratory Animals published by the U.S.
National Institutes of Health (National Institutes of Health
publication 85–23, revised 1996), and the regulations of the
Hungarian Act No. XXVIII of the year 1998 on protection
and care of animals were strictly followed. /e study was
approved by the local animal ethics committee of the
University of Szeged (XV.1181/2013).
Altogether 24 adult (8-week old) male Wistar rats were
used in this study (purchased from Charles River Labora-
tories, Go¨ttingen, Germany), weighing 270–324 g at the
onset of the experiments. Using only male rats in the study
was intentional as the hormonal changes during the men-
strual cycle of females have been shown to inﬂuence serum
lipids [10, 11]. Rats were kept under standard climatic
conditions (22± 2°C room temperature, 12 h light/dark
cycles), in pairs, in individually ventilated cages (Sealsafe
IVC system, Buguggiate, Italy) and had ad libitum access to
tap water and laboratory rat chow.
2.2. Experimental Setup. After one week of acclimatization,
the rats were randomized into three groups: control (Cont),
hypercholesterolemia (HChol), and hypercholesterolemia +
Stellaria media treatment (HChol + SM). Rats in the control
group (n� 8) received standard laboratory rat chow. /e
other 16 rats were fed a special cholesterol-enriched diet, i.e.,
a standard laboratory rat chow (Innovo Ltd., Isaszeg,
Hungary) supplemented with 2% (w/w) cholesterol (Hun-
garopharma, Budapest, Hungary) and 0.25% (w/w) sodium-
cholate-hydrate (Sigma-Aldrich, St. Louis, USA) for 8 weeks
to induce experimental hypercholesterolemia as described
earlier [12–14]. We have chosen this cost-eﬀective model of
experimental hypercholesterolemia because our research
group has previously accumulated extensive experience
regarding the use of this model [12–14] and the lipoprotein
proﬁle of the cholesterol-fed rats (LDL/HDL ratio) is quite
similar to that of humans. /e diet of 8 animals receiving
cholesterol-enriched chow was further supplemented with
Stellaria media tea lyophilizate mixed into cookie balls
(HChol + SM) in order to examine the potential cholesterol-
lowering eﬀect of Stellaria media. On the eighth week, rats
were anesthetized with sodium pentobarbital (Euthasol,
50mg/kg body weight, ip., Produlab Pharma b.v., Raams-
donksveer, /e Netherlands), the abdominal cavity was
opened, and blood samples were taken from the abdominal
aorta. Collected blood was allowed to clot and was centri-
fuged (2000× g, 20min, 4°C); then serum was separated for
analysis of various serum parameters to evaluate the eﬃcacy
and safety of Stellaria media treatment, including lipid
proﬁle and parameters representing liver and kidney
function. Before termination, echocardiography was per-
formed in order to evaluate the eﬀects of experimental
hypercholesterolemia and Stellaria media on cardiac mor-
phology and function.
2.3. Preparation of Stellaria media Tea Lyophilizate.
Stellaria media was harvested in Algyő (Hungary) by
“Ezerjo´f}u” Association in 2017. Voucher specimen (no: 882)
was deposited in the herbarium of the University of Szeged,
Faculty of Pharmacy, Department of Pharmacognosy. /e
drug was dried and stored at room temperature.
/e dried and grounded drug was extracted with boiling
water (1 :10 w/v ratio) for 15 minutes by ultrasonication./e
highly dense extract was separated from solid particles by
mechanical press, and the water extract was lyophilized.
Approximately, 1.5 g lyophilizate was obtained from 10.0 g
dried drug.
2.4. Stellaria media Administration. Rats in the HChol + SM
group received 100mg/kg body weight lyophilized Stellaria
media tea mixed into cookie balls once a day. /e recipe of
cookie dough included 55% plain ﬂour, 20% caster sugar, and
25%water [15]. All animals received 2 g cookie dough/kg body
weight per day. We have found in a pilot study that ad-
ministration of 2 g/kg body weight cookie dough for 7 days in
control rats did not cause signiﬁcant changes in levels of blood
cholesterol, triacylglycerol, or glucose (data not shown). /e
doughwas prepared once a week and kept at 4°C until use./e
100mg/kg body weight dose of lyophilized Stellaria media tea
was considered as equal to human daily dose, calculated
according to Nair and Jacob [16]. Individual portions of ly-
ophilized Stellaria media tea were freshly mixed with the
cookie balls right before administration. During the one-week
long acclimatization period, the rats were habituated to the
cookie balls in order to prevent neophobia and were trained to
accept the cookie balls voluntarily in their home cages. We
always made sure that the whole cookie ball was eaten, and the
success rate of this technique was 100% during the experi-
ment. Cookie balls were preferred instead of the traditional
gavage technique in order to cause less daily stress to the
animals and to model human exposure the most objectively.
2.5. Measurements of Serum Lipid Levels. Serum total cho-
lesterol, high-density lipoprotein (HDL) cholesterol, tri-
acylglycerol levels, and pancreatic lipase enzyme activities
were analyzed by using Roche Cobas 8000 analyzer system in
the Department of Laboratory Medicine using enzymatic
colorimetric assays from Roche (Mannheim, Germany).
Low-density lipoprotein (LDL) cholesterol levels were
measured using a kit from Diagnosticum, Budapest, Hun-
gary, adopted to a plate reader (FLUOstar Optima, BMG), as
described earlier [17].
2.6. Measurements of Serum Parameters Representing Liver
and Kidney Function. Several other serum parameters were
measured using Roche Cobas 8000 analyzer system to
monitor the eﬀect of diet-induced hypercholesterolemia as
well as Stellaria media treatment on liver and kidney func-
tions. Total protein, albumin, and creatinine concentrations as
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well as alkaline phosphatase (ALP) enzyme activities were
analyzed by colorimetric assays from Roche (Mannheim,
Germany). Alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) enzyme activities and carbamide
levels were measured with Roche UV assays (Mannheim,
Germany), as described earlier [14].
2.7. Transthoracic Echocardiography. Cardiac morphology
and function were assessed by transthoracic echocardiog-
raphy at week 8 as described previously [18–20]. Brieﬂy, rats
were anesthetized with sodium pentobarbital (Euthasol,
50mg/kg body weight ip.). /en, the chest was shaved and
the rat was placed in a supine position onto a heating pad.
Two-dimensional and M-mode echocardiographic exami-
nations were performed by the criteria of the American
Society of Echocardiography with a Vivid IQ ultrasound
system (General Electric Medical Systems, Boston, USA)
using a phased array 5.0–11MHz transducer (GE 12S-RS
probe). Data of three consecutive heart cycles were analyzed
(EchoPac Dimension software; General Electric Medical
Systems, Boston, USA) by an experienced investigator in a
blinded manner. /e mean values of three measurements
were calculated and used for statistical evaluation.
2.8. StatisticalAnalysis. Statistical analysis was performed by
using SigmaPlot 12.0 for Windows (Systat Software Inc). All
values are presented as mean± SEM. One-way ANOVA was
used to determine the diﬀerences among the three experi-
mental groups. p< 0.05 was accepted as statistically sig-
niﬁcant diﬀerence, using the Tukey post hoc test.
3. Results
3.1. Body Weight. Body weight showed a continuous in-
crease from 305± 4 g at the onset of the experiment to
505± 13 g at week 8 in the control group fed a normal diet
(Figure 1(a)). Neither cholesterol-enriched diet nor Stellaria
media treatment aﬀected body weight signiﬁcantly at any
time points (Figure 1(a)). Weight gain during the 8-week
feeding protocol was also not aﬀected signiﬁcantly by any of
the treatments (Figure 1(b)).
3.2. Serum Lipid Parameters. Lipid levels were measured
from serum in order to validate the development of diet-
induced hypercholesterolemia by the end of an 8-week
feeding protocol. Total cholesterol concentration was sig-
niﬁcantly elevated in the HChol and the HChol + SM groups
compared to the control group; however, there was no
signiﬁcant diﬀerence between HChol and HChol + SM
values (Figure 2(a)). Triacylglycerol levels showed no sig-
niﬁcant diﬀerence due to cholesterol-enriched diet or Stel-
laria media treatment (Figure 2(b)). Similarly to total
cholesterol, serum LDL cholesterol concentration was sig-
niﬁcantly higher in the HChol group, which was not aﬀected
by Stellaria media tea lyophilizate (Figure 2(c)). Serum HDL
cholesterol level was signiﬁcantly higher in the HChol group
compared to control values; however, Stellaria media
treatment did not aﬀect signiﬁcantly HDL cholesterol level
(Figure 2(d)). Serum pancreatic lipase enzyme activities were
not statistically diﬀerent among the three experimental
groups (Cont: 5.5± 0.27U/L, HChol: 7.25± 1.07U/L, and
HChol + SM: 6.13± 0.35U/L). /ese results suggest that
Stellaria media tea lyophilizate does not have triacylglycerol-
and cholesterol-lowering eﬀect.
3.3. Liver Weight and Function. Diet-induced hypercho-
lesterolemia caused marked alterations in some liver pa-
rameters. Liver weight, serum total protein, and albumin
concentrations, as well as ALP activity were signiﬁcantly
higher in the HChol group compared to the control group
(Figures 3(a)–3(d)). ALT and AST activities were not al-
tered due to diet-induced hypercholesterolemia
(Figures 3(e) and 3(f )). Stellaria media treatment did not
inﬂuence signiﬁcantly the hypercholesterolemia-induced
alterations (Figure 3). Interestingly, AST enzyme activities
were signiﬁcantly higher in the HChol + SM group com-
pared with the control group.
3.4. Kidney Function. Diet-induced hypercholesterolemia
and Stellaria media treatment did not inﬂuence the serum
parameters representing kidney function since there was no
signiﬁcant diﬀerence among the experimental groups in
serum carbamide and creatinine levels (Figure 4).
3.5. Transthoracic Echocardiography. Transthoracic echo-
cardiographic measurements performed at the end of the
feeding protocol showed that diet-induced hypercholester-
olemia and Stellaria media treatment did not aﬀect cardiac
morphology as there were no signiﬁcant diﬀerences in
systolic and diastolic wall thickness parameters (Table 1).
Parameters related to cardiac function including left ven-
tricular end-diastolic and end-systolic volume, stroke vol-
ume, ejection fraction, and heart rate were also not
inﬂuenced signiﬁcantly by diet-induced hypercholesterol-
emia and Stellaria media treatment (Table 1).
4. Discussion
In folk medicine, Stellaria media is mostly consumed as tea
and is believed to decrease blood cholesterol level. In ac-
cordance, several tea products are available with this claim or
indication. Nevertheless, the cholesterol-lowering eﬀect of
Stellaria media tea has not been investigated previously.
In our present study, we intended to model the human
use of chickweed as close as possible. For this reason,
according to folk medicinal practice, only above-ground
parts of Stellaria media were used. /e extract was prepared
as tea infusion like in human use, and the dosage was
calculated according to the typical human dose. Since we
were primarily interested in the potential cholesterol-low-
ering eﬀect of Stellaria media, we applied an experimental
model of diet-induced hypercholesterolemia that has been
previously characterised and extensively used in our labo-
ratory [12–14]. In our present study, we did not conﬁrm the
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cholesterol-lowering eﬀect of Stellaria media tea. No alter-
ations in lipid metabolism were observed since pancreatic
lipase activity was not inhibited, and blood lipid proﬁle (i.e.,
total cholesterol, triacylglycerol, LDL, and HDL cholesterol)
was not signiﬁcantly diﬀerent compared to the untreated
hypercholesterolemic group.
In the literature, the antiobesity eﬀect of Stellaria media
was examined using various rodent obesity models [21–23].
Only one of these studies demonstrated a cholesterol-lowering
eﬀect of Stellaria media administered as 900mg/kg body
weight lyophilized juice in a high-fat diet-induced obesity
model in male Swiss albino mice [23]. In the same study, the
lyophilized juice of Stellaria media also reduced the high-fat
diet-induced increase in triacylglycerol level and body weight.
Nevertheless, lyophilized juice at 400mg/kg body weight had
no beneﬁcial eﬀects. /e contradictions of these ﬁndings with
our results are likely due to signiﬁcant diﬀerences in the
experimental setups. /e major diﬀerence is the type and
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Figure 1: Body weight (a) and weight gain after 8 weeks (b) in the control group (white spheres) and rats fed with cholesterol-enriched diet
(black triangles) or cholesterol-enriched diet with Stellaria media extract (grey squares). Results are means± SEM (n� 8 in each group),
analyzed by one-way ANOVA with Tukey post hoc test.
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Figure 2: Serum total cholesterol (a), serum triacylglycerol (b), LDL cholesterol (c), and HDL cholesterol (d) levels in rats fed either
cholesterol-enriched (HChol), cholesterol-enriched + Stellaria media (HChol + SM), or normal diet (Cont). Results are means± SEM (n� 8
in each group), analyzed by one-way ANOVA with the Tukey post hoc test. ∗p< 0.05 vs. control, ∗∗p< 0.01 vs. control.
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dose of Stellaria media extracts used in the studies. We treated
animals with Stellaria media tea lyophilizate at a dose of
100mg/kg body weight, while the other research group used
lyophilized herb juice at an eﬀective dose of 900mg/kg body
weight. /e diﬀerent extraction methods likely resulted in
qualitative and quantitative diﬀerences in the active sub-
stances of the extracts, and the dose of the lyophilized juice of
Stellaria media seems to be unrealistically high.
In two other publications, ethanolic and methanolic
extracts of Stellaria media were tested in progesterone-in-
duced obesity [22] or in cafeteria diet-induced obesitymodels
in female rats or mice [21]. Administration of 400mg/kg
body weight methanolic extract decreased triacylglycerol
levels in both obesity models, but it did not aﬀect total
cholesterol levels. /e ethanolic extract had no beneﬁcial
eﬀects in these studies. It is worth mentioning that the ad-
ministration of methanolic extract has no relevance in hu-
man use and the assessment of the ethnopharmacological
application of chickweed. Unfortunately, credibility of the
data in these latter two papers is rather questionable because
there are numerous contradictions between the reported data
in the tables and the description and interpretation of the
ﬁndings in the text. Furthermore, the results are not com-
parable with the ﬁndings of other reports since the poorly
described extraction method is unclear.
We have also investigated some safety issues, and based
on our results, SM treatment does not seem to have a severe
toxic eﬀect on the liver or the kidneys, since several liver
0
5
10
15
20
25
Li
ve
r w
ei
gh
t (
g)
∗∗ ∗∗
Cont HChol HChol + SM
(a)
0
20
40
60
80
To
ta
l p
ro
te
in
 (m
g/
L)
∗∗ ∗∗
Cont HChol HChol + SM
(b)
0
10
20
30
40
50
A
lb
um
in
 (m
g/
L)
∗∗
Cont HChol HChol + SM
(c)
0
40
80
120
A
LP
 (U
/L
)
∗
∗
Cont HChol HChol + SM
(d)
0
10
20
30
40
Cont HChol HChol + SM
A
LT
 (U
/L
)
(e)
0
40
80
120
160
200
A
ST
 (U
/L
)
∗
Cont HChol HChol + SM
(f )
Figure 3: Liver weight (a), serum total protein levels (b), albumin levels (c), alkaline phosphatase (ALP) activity (d), alanine amino-
transferase (ALT) activity (e), and aspartate aminotransferase (AST) activity (f ) in rats fed either cholesterol-enriched (HChol), cholesterol-
enriched + Stellaria media (HChol + SM), or normal diet (Cont). Results are means± SEM (n� 8 in each group), analyzed by one-way
ANOVA with the Tukey post hoc test. ∗p< 0.05 vs. control, ∗∗p< 0.01 vs. control.
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Figure 4: Serum carbamide (a) and creatinine (b) levels in rats fed either cholesterol-enriched (HChol), cholesterol-enriched + Stellaria
media (HChol + SM), or normal diet (Cont). Results are means± SEM (n� 8 in each group), analyzed by one-way ANOVA with the Tukey
post hoc test.
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marker enzymes were elevated in the HChol group without
being aﬀected by SM treatment (total protein, albumin, and
ALP). Although AST enzyme activities were elevated in the
HChol + SM group compared with the control group, the
ASTactivity in the HChol + SM group did not diﬀer from the
values measured in the HChol group. Elevated AST level in
the blood is often considered as a sign of liver damage;
however, AST is not speciﬁc for the liver and may be also
increased due to injuries of the heart, muscle, pancreas,
kidney, or red blood cells [24]. Interestingly, SM treatment
actually was found to be hepatoprotective in a liver toxicity
model [25]. Overall these data suggest that Stellaria media
treatment has no deleterious eﬀect on liver function;
however, a possible limitation of our study is the lack of a
group receiving herbal treatment without cholesterol-
enriched chow.
5. Conclusions
In our current study, we have also investigated some safety
issues and found that Stellaria media was neither toxic nor
caused alterations in liver or kidney functions and cardiac
morphology compared with hypercholesterolemic rats. /is
suggests a safe use of Stellaria media tea. /e human use of
chickweed tea for lowering blood cholesterol level was ex-
amined in vivo in rats, using an experimental design to
mimic the human use of the herb. Since the body weight and
blood lipid proﬁle were not signiﬁcantly altered in the group
treated with Stellaria media compared with the group fed
with cholesterol-enriched diet only, our experiment does not
support the rationale for using chickweed tea in order to
lower cholesterol level.
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Table 1: Eﬀects of Stellaria media on left ventricular morphological and functional parameters. Transthoracic echocardiographic mea-
surement values in rats fed either cholesterol-enriched (HChol), cholesterol-enriched + Stellaria media (HChol + SM), or normal diet
(Cont). Results are means± SEM (n� 8 in each group), analyzed by one-way ANOVA with the Tukey post hoc test. 2D: two dimensional;
4CH: four chambers view; MM: M (motion) Mode; ns: not signiﬁcant.
Parameter (unit) View/mode
Week 8
Signiﬁcance
Cont HChol HChol + SM
Anterior wall thickness-systolic (mm) Short axis/MM 3.57± 0.11 3.41± 0.17 3.10± 0.12 ns
Anterior wall thickness-diastolic (mm) Short axis/MM 2.20± 0.11 2.22± 0.17 2.16± 0.11 ns
Inferior wall thickness-systolic (mm) Short axis/MM 3.85± 0.11 3.46± 0.15 3.69± 0.09 ns
Inferior wall thickness-diastolic (mm) Short axis/MM 2.14± 0.09 2.13± 0.14 2.19± 0.13 ns
Posterior wall thickness-systolic (mm) Long axis/MM 3.82± 0.08 3.68± 0.12 3.62± 0.09 ns
Posterior wall thickness-diastolic (mm) Long axis/MM 2.19± 0.03 2.39± 0.13 2.52± 0.19 ns
Septal wall thickness-systolic (mm) Long axis/MM 3.79± 0.06 3.62± 0.12 3.54± 0.17 ns
Septal wall thickness-diastolic (mm) Long axis/MM 2.50± 0.11 2.24± 0.10 2.35± 0.11 ns
Left ventricular end-diastolic volume (μl) 4CH/2D 127± 15 129± 13 105± 13 ns
Left ventricular end-systolic volume (μl) 4CH/2D 49± 8 53± 5 46± 6 ns
Stroke volume (μl) 4CH/2D 79± 8 76± 8 59± 8 ns
Ejection fraction (%) 4CH/2D 63± 2 59± 1 56± 3 ns
Heart rate (1/min) 4CH/2D 343± 14 367± 8 370± 11 ns
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